Thursday, November 24, 2016

Oncogene - Table of Contents alert Volume 35 Issue 47

If you are unable to see the message below, click here to view.


Volume 35, Issue 47 (November 2016)

In this issue
Original Articles

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



Targeting CK2-driven non-oncogene addiction in B-cell tumors

E Mandato, S Manni, F Zaffino, G Semenzato and F Piazza

Oncogene 2016 35: 6045-6052; advance online publication, April 4, 2016; 10.1038/onc.2016.86

Abstract | Full Text

Original Articles


The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

J Turpin, C Ling, E J Crosby, Z C Hartman, A M Simond, L A Chodosh, J P Rennhack, E R Andrechek, J Ozcelik, M Hallett, G B Mills, R D Cardiff, J W Gray, O L Griffith and W J Muller

Oncogene 2016 35: 6053-6064; advance online publication, May 9, 2016; 10.1038/onc.2016.129

Abstract | Full Text

Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals

Y Cui, Y Sun, S Hu, J Luo, L Li, X Li, S Yeh, J Jin and C Chang

Oncogene 2016 35: 6065-6076; advance online publication, July 4, 2016; 10.1038/onc.2016.135

Abstract | Full Text

Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies

P Bernasconi-Elias, T Hu, D Jenkins, B Firestone, S Gans, E Kurth, P Capodieci, J Deplazes-Lauber, K Petropoulos, P Thiel, D Ponsel, S Hee Choi, P LeMotte, A London, M Goetcshkes, E Nolin, M D Jones, K Slocum, M J Kluk, D M Weinstock, A Christodoulou, O Weinberg, J Jaehrling, S A Ettenberg, A Buckler, S C Blacklow, J C Aster and C J Fryer

Oncogene 2016 35: 6077-6086; advance online publication, May 9, 2016; 10.1038/onc.2016.133

Abstract | Full Text

Leukemic survival factor SALL4 contributes to defective DNA damage repair

F Wang, C Gao, J Lu, H Tatetsu, D A Williams, L U Müller, W Cui and L Chai

Oncogene 2016 35: 6087-6095; advance online publication, May 2, 2016; 10.1038/onc.2016.146

Abstract | Full Text

Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3′UTR and 5′UTR of Jab1/CSN5

S Wang, Y Pan, R Zhang, T Xu, W Wu, R Zhang, C Wang, H Huang, C A Calin, H Yang and F X Claret

Oncogene 2016 35: 6096-6108; advance online publication, May 9, 2016; 10.1038/onc.2016.147

Abstract | Full Text

Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells

R Yao, J Oyanagi, Y Natsume, D Kusama, Y Kato, S Nagayama and T Noda

Oncogene 2016 35: 6109-6119; advance online publication, May 9, 2016; 10.1038/onc.2016.148

Abstract | Full Text

GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma

S Yuan, Z Yu, Q Liu, M Zhang, Y Xiang, N Wu, L Wu, Z Hu, B Xu, T Cai, X Ma, Y Zhang, C Liao, L Wang, P Yang, L Bai and Y Li

Oncogene 2016 35: 6120-6131; advance online publication, May 9, 2016; 10.1038/onc.2016.149

Abstract | Full Text

A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer

Y Ma, C Yu, E M Mohamed, H Shao, L Wang, G Sundaresan, J Zweit, M Idowu and X Fang

Oncogene 2016 35: 6132-6142; advance online publication, May 2, 2016; 10.1038/onc.2016.150

Abstract | Full Text

Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis

M F Montenegro, L Sánchez-del-Campo, R González-Guerrero, E Martínez-Barba, A Piñero-Madrona, J Cabezas-Herrera and J N Rodríguez-López

Oncogene 2016 35: 6143-6152; advance online publication, May 2, 2016; 10.1038/onc.2016.154

Abstract | Full Text



The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation

C M Das, P Taylor, M Gireud, A Singh, D Lee, G Fuller, L Ji, J Fangusaro, V Rajaram, S Goldman, C Eberhart and V Gopalakrishnan

Oncogene 2016 35: 6153-6154; advance online publication, July 18, 2016; 10.1038/onc.2016.141

Full Text

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma

S Sankar, R Bell, B Stephens, R Zhuo, S Sharma, D J Bearss and S L Lessnick

Oncogene 2016 35: 6155-6156; advance online publication, June 27, 2016; 10.1038/onc.2016.142

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: